Transfusion Medicine Reviews最新文献

筛选
英文 中文
Examining Injustices: Transfusion Medicine and Race 审视不公正现象:输血医学与种族
IF 2.7 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-07-01 DOI: 10.1016/j.tmrv.2024.150822
{"title":"Examining Injustices: Transfusion Medicine and Race","authors":"","doi":"10.1016/j.tmrv.2024.150822","DOIUrl":"10.1016/j.tmrv.2024.150822","url":null,"abstract":"<div><p>Race and ethnicity are sociopolitical and not biological constructs, and assertions that these population descriptors have scientific meaning has caused significant harm. A critical assessment of the transfusion medicine literature is an important aspect of promoting race-conscious as opposed to race-based medicine. Utilizing current definitions and health equity frameworks, this review will provide a critical appraisal of transfusion medicine studies at the intersection of race and healthcare disparities, with a focus on larger methodological challenges facing the transfusion medicine community. Moving forward, risk modelling accounting for upstream factors, patient input, as well as an expert consensus on how to critically conduct and evaluate this type of literature are needed. Further, when using race and ethnicity in research contexts, investigators must be aware of existing guidelines for such reporting.</p></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 3","pages":"Article 150822"},"PeriodicalIF":2.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139920087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis E Virus in the United States and Canada: Is It Time to Consider Blood Donation Screening? 美国和加拿大的戊型肝炎病毒:是时候考虑献血筛查了吗?
IF 2.7 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-07-01 DOI: 10.1016/j.tmrv.2024.150835
Marc Bienz , Christian Renaud , Jia Ru Liu , Philip Wong , Patricia Pelletier
{"title":"Hepatitis E Virus in the United States and Canada: Is It Time to Consider Blood Donation Screening?","authors":"Marc Bienz ,&nbsp;Christian Renaud ,&nbsp;Jia Ru Liu ,&nbsp;Philip Wong ,&nbsp;Patricia Pelletier","doi":"10.1016/j.tmrv.2024.150835","DOIUrl":"10.1016/j.tmrv.2024.150835","url":null,"abstract":"<div><p>Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis in the world and can lead to severe complications in immunocompromised individuals. HEV is primarily transmitted through eating pork, which has led to an increased in anti-HEV IgG seropositivity in the general population of Europe in particular. However, it can also be transmitted intravenously, such as through transfusions. The growing evidence of HEV contamination of blood products and documented cases of transmission have given rise to practice changes and blood product screening of HEV in many European countries. This review covers the abundant European literature and focuses on the most recent data pertaining to the prevalence of HEV RNA positivity and IgG seropositivity in the North American general population and in blood products from Canada and the United States. Currently, Health Canada and the Food and Drug Administration do not require testing of HEV in blood products. For this reason, awareness among blood product prescribers about the possibility of HEV transmission through blood products is crucial. However, we also demonstrate that the province of Quebec has a prevalence of anti-HEV and HEV RNA positivity similar to some European countries. In light of this, we believe that HEV RNA blood donation screening be reevaluated with the availability of more cost-effective assays.</p></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 3","pages":"Article 150835"},"PeriodicalIF":2.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141768065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does the Use of Viscoelastic Hemostatic Assays for Periprocedural Hemostasis Management in Liver Disease Improve Clinical Outcomes? 使用粘弹性止血测定法对肝病患者进行围手术期止血风险管理是否能改善临床疗效?
IF 2.7 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-07-01 DOI: 10.1016/j.tmrv.2024.150823
{"title":"Does the Use of Viscoelastic Hemostatic Assays for Periprocedural Hemostasis Management in Liver Disease Improve Clinical Outcomes?","authors":"","doi":"10.1016/j.tmrv.2024.150823","DOIUrl":"10.1016/j.tmrv.2024.150823","url":null,"abstract":"<div><p>Routine hemostasis parameters such as prothrombin time and fibrinogen are frequently abnormal in patients with chronic liver disease and have been demonstrated to be poor predictors for periprocedural bleeding. Alterations in procoagulant and anticoagulant factors in this population result in a state of rebalanced hemostasis, which is not reflected by routine hemostatic measures. Viscoelastic hemostatic assays (VHA) present a point of care measure of global hemostasis with an emerging role in guiding transfusion in the liver transplant setting. The potential role for VHA in guiding periprocedural transfusion is unknown. Here we critically appraise the available limited evidence on the use of VHA to guide prophylactic treatment in patients with cirrhosis undergoing procedures. We assess whether the impact of a VHA-guided approach improves clinical outcomes. Suggested areas for future research with a focus on clinically relevant outcomes, particularly periprocedural bleeding, are highlighted.</p></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 3","pages":"Article 150823"},"PeriodicalIF":2.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0887796324000130/pdfft?md5=8da73bb8b52705db5a41f1b79c6390fb&pid=1-s2.0-S0887796324000130-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140197592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Journal Club 期刊俱乐部
IF 2.7 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-07-01 DOI: 10.1016/j.tmrv.2024.150838
{"title":"Journal Club","authors":"","doi":"10.1016/j.tmrv.2024.150838","DOIUrl":"https://doi.org/10.1016/j.tmrv.2024.150838","url":null,"abstract":"","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 3","pages":"Article 150838"},"PeriodicalIF":2.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141543224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxygen Extraction Ratios to Guide Red Blood Cell Transfusion 指导红细胞输注的氧气提取率
IF 2.7 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-07-01 DOI: 10.1016/j.tmrv.2024.150834
{"title":"Oxygen Extraction Ratios to Guide Red Blood Cell Transfusion","authors":"","doi":"10.1016/j.tmrv.2024.150834","DOIUrl":"10.1016/j.tmrv.2024.150834","url":null,"abstract":"<div><p>Hemoglobin-based red blood cell transfusion (RBC) triggers do not clearly identify which patients with moderate anemia (hemoglobin 7-10 g/dL) will benefit from RBC transfusion. The National Heart, Lung, and Blood Institute has recognized the need for bedside oxygenation measures to enhance transfusion decision-making. This narrative review uses four studies to explore the potential of the oxygen extraction ratio (O<sub>2</sub>ER)—the ratio of consumed oxygen to delivered oxygen in a critical tissue bed as a more physiologically relevant indicator for guiding RBC transfusions in patients with moderate anemia. The aim of this review is to present existing data on the relationship between O<sub>2</sub>ER and responsiveness to RBC transfusion, as well as the feasibility of O<sub>2</sub>ER as bedside measure of tissue oxygenation. This review presents a narrative appraisal of three critical papers that investigate the relationship between O<sub>2</sub>ER and transfusion outcomes, and one paper that demonstrates proof-of-concept for a noninvasive device to measure O<sub>2</sub>ER at the bedside. Despite limitations in the existing studies, including small sample sizes and observational designs, the evidence collectively suggests that O<sub>2</sub>ER has the potential to enhance transfusion decision accuracy. The development of noninvasive measurement devices could facilitate widespread implementation in many kinds of care settings.</p></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 3","pages":"Article 150834"},"PeriodicalIF":2.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141040705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Transfusion Practices in Adults Having Noncardiac Surgery 非心脏手术成人围手术期输血实践
IF 2.7 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-07-01 DOI: 10.1016/j.tmrv.2024.150839
Michael Verret , Manoj Lalu , Daniel I. Sessler , Flavia K. Borges , Pavel S. Roshanov , Alexis F. Turgeon , Xavier Neveu , Tim Ramsay , Wojciech Szczeklik , Vikas Tandon , Ameen Patel , Bruce Biccard , PJ Devereaux , Dean A. Fergusson
{"title":"Perioperative Transfusion Practices in Adults Having Noncardiac Surgery","authors":"Michael Verret ,&nbsp;Manoj Lalu ,&nbsp;Daniel I. Sessler ,&nbsp;Flavia K. Borges ,&nbsp;Pavel S. Roshanov ,&nbsp;Alexis F. Turgeon ,&nbsp;Xavier Neveu ,&nbsp;Tim Ramsay ,&nbsp;Wojciech Szczeklik ,&nbsp;Vikas Tandon ,&nbsp;Ameen Patel ,&nbsp;Bruce Biccard ,&nbsp;PJ Devereaux ,&nbsp;Dean A. Fergusson","doi":"10.1016/j.tmrv.2024.150839","DOIUrl":"https://doi.org/10.1016/j.tmrv.2024.150839","url":null,"abstract":"<div><p>Surgical patients are often transfused to manage bleeding and anemia. Best practices for red blood cell (RBC) transfusion administration in patient having noncardiac surgery remains controversial and a robust evaluation and description of perioperative transfusion practices is lacking. We characterized perioperative hemoglobin concentrations and transfusion practices from the prospective VISION cohort which included 39,222 patients aged ≥45 years who had inpatient noncardiac surgery. Variations in transfusion practices were analyzed using hierarchical mixed models, and associations with mortality and complications were evaluated using a nested frailty survival model. Within the cohort, 16.1% (n = 6296) were given perioperative RBC transfusions, with the fraction declining from 20% to 13% over the 6-year study period. The proportion of patients transfused varied by surgery type from 6.4% for low-risk operations (i.e., minor surgery) to 31.5% for orthopedic surgeries. Variations were largely associated with patient hemoglobin concentrations, but also with center (range: 3.7%-27.3%) and country (0.4%-25.3%). Even after adjusting for baseline hemoglobin, comorbidities and type of surgery, both center and country were significant sources of variation in transfusion practices. Among transfused participants, 60.4% (n = 3728/6170) had at least 1 hemoglobin concentration ≤80g/L and 86.0% (n = 5305/6170) had at least 1 hemoglobin concentration ≤90g/L, suggesting that relatively restrictive transfusion strategies were used in most. The proportion of patients receiving at least 1 RBC transfusion declined from 20% to 13% over 6 years. However, there was considerable unexplained variation in transfusion practices.</p></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 3","pages":"Article 150839"},"PeriodicalIF":2.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0887796324000294/pdfft?md5=99da365696087f5cd9ccb8317c36800e&pid=1-s2.0-S0887796324000294-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141606530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased Serum Levels of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) in Mobilized Healthy Donors with G-CSF: A Cohort Study 使用 G-CSF 的健康捐献者血清中 N 端前 B 型钠尿肽(NT-proBNP)水平升高:一项队列研究
IF 4.5 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-04-01 DOI: 10.1016/j.tmrv.2024.150824
Joan Cid , Katia Guinetti-Ortiz , Paola Charry , Gloria Carbassé , Mar de Pablo-Miró , Laura Rubia , Marta Garcia , Jose Alcaraz-Quiles , Enric Cascos , Nuria Martínez-Cibrian , María Queralt Salas , Maria Suárez-Lledó , Laura Rosiñol , Francesc Fernández-Avilés , Carmen Martínez , Montserrat Rovira , Miquel Lozano
{"title":"Increased Serum Levels of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) in Mobilized Healthy Donors with G-CSF: A Cohort Study","authors":"Joan Cid ,&nbsp;Katia Guinetti-Ortiz ,&nbsp;Paola Charry ,&nbsp;Gloria Carbassé ,&nbsp;Mar de Pablo-Miró ,&nbsp;Laura Rubia ,&nbsp;Marta Garcia ,&nbsp;Jose Alcaraz-Quiles ,&nbsp;Enric Cascos ,&nbsp;Nuria Martínez-Cibrian ,&nbsp;María Queralt Salas ,&nbsp;Maria Suárez-Lledó ,&nbsp;Laura Rosiñol ,&nbsp;Francesc Fernández-Avilés ,&nbsp;Carmen Martínez ,&nbsp;Montserrat Rovira ,&nbsp;Miquel Lozano","doi":"10.1016/j.tmrv.2024.150824","DOIUrl":"10.1016/j.tmrv.2024.150824","url":null,"abstract":"<div><p>Limited data regarding elevation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in mobilized donors with G-CSF is available. We extended these findings by examining serum NT-proBNP in a cohort study including 35 healthy donors and 69 patients who received G-CSF for CD34+ mobilization as well as 54 patients who did not receive G-CSF but who underwent collection of CD3+ cells for chimeric antigen receptor (CAR) T-cell manufacturing. No donor in the three cohorts experienced significant cardiac adverse events. NT-proBNP levels were measured before and after G-CSF administration and after finishing apheresis procedure. NT-proBNP increase was observed in mobilized healthy donors after G-CSF administration, but was not observed in mobilized or non-mobilized patients. Only in the cohort of healthy donors, pairwise comparisons using Wilcoxon signed ranks test showed a significant increase between the mean serum NT-proBNP level after G-CSF administration and the mean serum NT-proBNP level measured before G-CSF administration (231.09 ± 156.15 pg/mL vs. 58.88 ± 26.84 pg/mL; <em>P</em> &lt; .01). No correlation was observed between NT-proBNP increase and G-CSF dose (r<sub>s</sub> = 0.09; <em>n</em> = 32; <em>P</em> = .6) and no other variables contributing to predict serum NT-proBNP increase were detected. In conclusion, we observed a statistically, although not clinically, significant increase of NT-proBNP in healthy donors who received G-CSF as CD34+ cell mobilization.</p></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 2","pages":"Article 150824"},"PeriodicalIF":4.5,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140150683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare Inherited Bleeding Disorders in The Middle East 中东地区罕见的遗传性出血性疾病
IF 4.5 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-04-01 DOI: 10.1016/j.tmrv.2024.150825
Arefeh Mazhari , Maryam Khajavi , Hassan Mansouritorghabeh
{"title":"Rare Inherited Bleeding Disorders in The Middle East","authors":"Arefeh Mazhari ,&nbsp;Maryam Khajavi ,&nbsp;Hassan Mansouritorghabeh","doi":"10.1016/j.tmrv.2024.150825","DOIUrl":"10.1016/j.tmrv.2024.150825","url":null,"abstract":"","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 2","pages":"Article 150825"},"PeriodicalIF":4.5,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140156527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HemoCue Hb-801 Provides More Accurate Hemoglobin Assessment in Blood Donors Than OrSense NBM-200 与 OrSense NBM-200 相比,HemoCue Hb-801 可对献血者进行更准确的血红蛋白评估
IF 4.5 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-04-01 DOI: 10.1016/j.tmrv.2024.150826
Lisa Seekircher , Anita Siller , Marco Amato , Lena Tschiderer , Agnes Balog , Manfred Astl , Harald Schennach , Peter Willeit
{"title":"HemoCue Hb-801 Provides More Accurate Hemoglobin Assessment in Blood Donors Than OrSense NBM-200","authors":"Lisa Seekircher ,&nbsp;Anita Siller ,&nbsp;Marco Amato ,&nbsp;Lena Tschiderer ,&nbsp;Agnes Balog ,&nbsp;Manfred Astl ,&nbsp;Harald Schennach ,&nbsp;Peter Willeit","doi":"10.1016/j.tmrv.2024.150826","DOIUrl":"10.1016/j.tmrv.2024.150826","url":null,"abstract":"<div><p>Hemoglobin levels are commonly assessed to prevent causing or worsening of anemia in prospective blood donors. We compared head-to-head the accuracy of different technologies for measuring hemoglobin suitable for use in mobile donation units. We included 144 persons donating platelets at the Central Institute for Blood Transfusion and Immunology in Innsbruck, Austria. Hemoglobin levels were measured in venous blood using the portable hemoglobinometer HemoCue Hb-801 and noninvasively using OrSense NBM-200, and compared to values obtained with the Sysmex XN-430, an automated hematology analyzer employing the sodium lauryl sulphate method, which is broadly used as reference method in everyday clinical practice. Mean age of participants was 34.2 years (SD 13.0); 34.0% were female. Hemoglobin values measured with HemoCue were more strongly correlated with the Sysmex XN-430 (r = 0.90 [95% CI: 0.87-0.93]) than measured with OrSense (r = 0.49 [0.35-0.60]). On average, HemoCue overestimated hemoglobin by 0.40 g/dL (0.31-0.48) and OrSense by 0.75 g/dL (95% CI: 0.54-0.96). When using OrSense, we found evidence for higher overestimation at higher hemoglobin levels (proportional bias) specifically in females but not in males (P<sub>difference</sub> = .003). Sensitivity and specificity for classifying donors according to the hemoglobin donation thresholds were 99.2% (95% CI: 95.3%-100.0%) and 43.8% (23.1%-66.8%) for HemoCue vs 95.3% (89.9%-98.0%) and 12.5% (2.2%-37.3%) for OrSense. Areas under the receiver operating characteristic curves were higher using HemoCue vs OrSense both in females (0.933 vs 0.547; <em>P</em> = .044) and males (0.948 vs 0.628; <em>P</em> &lt; .001). HemoCue Hb-801 measures hemoglobin more accurately than OrSense NBM-200 in the setting of mobile blood donation units. Our findings are particularly relevant for females, having in mind that anemia is more prevalent in females than in males.</p></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 2","pages":"Article 150826"},"PeriodicalIF":4.5,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0887796324000166/pdfft?md5=2f67c5e2702087b17f48d5faffbdd12e&pid=1-s2.0-S0887796324000166-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140401935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Process Mining Uncovers Actionable Patterns of Red Blood Cell Unit Wastage in a Health Care Network 流程挖掘发现医疗网络中红细胞浪费的可行模式
IF 4.5 2区 医学
Transfusion Medicine Reviews Pub Date : 2024-03-29 DOI: 10.1016/j.tmrv.2024.150827
Neal I Callaghan , Jason Quinn , Robert Liwski , Natalie Chisholm , Calvino Cheng
{"title":"Process Mining Uncovers Actionable Patterns of Red Blood Cell Unit Wastage in a Health Care Network","authors":"Neal I Callaghan ,&nbsp;Jason Quinn ,&nbsp;Robert Liwski ,&nbsp;Natalie Chisholm ,&nbsp;Calvino Cheng","doi":"10.1016/j.tmrv.2024.150827","DOIUrl":"10.1016/j.tmrv.2024.150827","url":null,"abstract":"<div><p>Packed red blood cell transfusions are integral to the care of the critically and chronically ill patient, but require careful storage and a large, coordinated network to ensure their integrity during distribution and administration. Auditing a Transfusion Medicine service can be challenging due to the complexity of this network. Process mining is an analytical technique that allows for the identification of high-efficiency pathways through a network, as well as areas of challenge for targeted innovation. Here, we detail a case study of an efficiency audit of the Transfusion Medicine service of the Nova Scotia Health Administration Central Zone using process mining, across a period encompassing years prior to, during, and after the acute COVID-19 pandemic. Service efficiency from a product wastage perspective was consistently demonstrated at benchmarks near globally published optima. Furthermore, we detail key areas of continued challenge in product wastage, and suggest potential strategies for further targeted optimization.</p></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 3","pages":"Article 150827"},"PeriodicalIF":4.5,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0887796324000178/pdfft?md5=dbb685a5cf6e4435dc0b8a8972f11b8c&pid=1-s2.0-S0887796324000178-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140402506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信